Finance

Lists
Why is 530317 up 2,77%?
Dive Deeper
530317:BOM
Godavari Drugs Ltd
133,40 ₹
+2,77%
(+3,60) 1D
16 қаз., 15:50:43 GMT+5:30  ·   INR
All symbols
SymbolPriceChange% Change
Generating top insights for 530317...
Open
129,80 ₹
High
134,00 ₹
Low
129,40 ₹
Mkt. cap
1,46 млрд
Avg. vol.
15,26 мың
Volume
1,06 мың
P/E ratio
26,34
52-wk high
144,35 ₹
52-wk low
69,70 ₹
EPS
5,06 ₹
Shares outstanding
7,53 млн
No. of employees
112
Open
129,80 ₹
High
134,00 ₹
Low
129,40 ₹
Mkt. cap
1,46 млрд
Avg. vol.
15,26 мың
Volume
1,06 мың
P/E ratio
26,34
52-wk high
144,35 ₹
52-wk low
69,70 ₹
EPS
5,06 ₹
Shares outstanding
7,53 млн
No. of employees
112
News stories
From web sources and news partners
About Godavari Drugs Ltd
CEO-
Employees112
Founded1987
Headquarters-
SectorPharmaceutical industry
Previous reportsAll values in INR
Loading Previous Earnings...
Revenue
Net income
All values in INR
2025 ж. қыр.
2025 ж. жел.
2026 ж. нау.
2026 ж. мау.
Revenue
272,85 млн
222,01 млн
324,99 млн
281,08 млн
Cost of goods sold
201,10 млн
148,82 млн
261,64 млн
198,04 млн
Cost of revenue
201,10 млн
148,82 млн
261,64 млн
198,04 млн
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
14,43 млн
15,77 млн
15,07 млн
14,77 млн
Operating expense
51,45 млн
54,37 млн
40,29 млн
62,30 млн
Total operating expenses
252,55 млн
203,19 млн
301,93 млн
260,35 млн
Operating income
20,30 млн
18,82 млн
23,06 млн
20,73 млн
Other non operating income
-
-
6,44 млн
-
EBT including unusual items
11,21 млн
10,22 млн
16,18 млн
11,77 млн
EBT excluding unusual items
11,21 млн
7,70 млн
15,14 млн
11,77 млн
Income tax expense
1,21 млн
2,64 млн
3,27 млн
682,00 м.
Effective tax rate
10,76%
25,86%
20,20%
5,79%
Other operating expenses
30,98 млн
32,49 млн
19,10 млн
41,61 млн
Net income
10,01 млн
7,58 млн
12,91 млн
11,09 млн
Net profit margin
3,67%
3,41%
3,97%
3,95%
Earnings per share
-
-
-
-
Interest and investment income
-
-
1,61 млн
-
Interest expense
-9,08 млн
-11,11 млн
-9,56 млн
-8,96 млн
Net interest expenses
-9,08 млн
-11,11 млн
-7,95 млн
-8,96 млн
Depreciation and amortization charges
6,04 млн
6,12 млн
6,12 млн
5,93 млн
EBITDA
26,34 млн
24,94 млн
29,15 млн
26,81 млн
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
Google қолданбалары